test3-bg-1920

Helping transform medical discovery and innovation into viable solutions that can impact the world

halteres-logo

HALTERES' MAIN FOCUS AREAS

Maximizing Value

Understanding market needs. Learn More »»

Portfolio Planning

Balancing technical difficulty of development with commercial attractiveness. Learn More »»

Informatics in Molecular Medicine

The use of multi-methodology algorithms in medical practice today. Learn More »»

The Role of Impact Modeling

Establishing the “value” in high-value diagnostics. Learn More »»

Delivering Diagnostics for Global Health

Understanding needs and developing diagnostic solutions that improve linkage to care in low resource settings. Learn More »»

Point of Care Testing

Renewed interest in decentralized or Point of Care Testing: what’s changed?. Learn More »»

Consumer Digital and Mobile Health

Understanding regulatory, payment and education challenges in the consumer digital health space. Learn More »»

Latest News

CROI 2019 March 4-7, 2019

Dr. Mickey S. Urdea will participate in the CROI Conference in Seattle, Washington. The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. The CROI Foundation partners with the International Antiviral Society–USA (IAS–USA) for organization of the conference.

Molecular Diagnostics & Digital Health March 11-13, 2019

Mr. Richard M. Thayer will attend the Digital Health: Sensors, Wearables and IoT program of the Molecular Diagnostics Strategy and Outlook Executive Summit, part of the Molecular Medicine Tri-Conference in San Francisco, California. Molecular diagnostics along with healthcare in general are undergoing technology-driven revolution. Novel detection assays and sensors, digital biomarkers and machine learning approaches have become key drivers for innovation in drug development and patient care. This channel will feature the latest technology breakthroughs as well as partnering, regulatory and reimbursement solutions for implementation into value-based patient-centered care.

71st AACC Annual Scientific Meeting August 4-8, 2019

Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. AACC provides an unparalleled opportunity to connect with global leaders in laboratory medicine and to discover cutting edge technology and learn about vital research in the field. AACC is the meeting place for global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

November 2017 Diagnostics Report Issue 1 (PDF)

J.P. Morgan Healthcare Conference January 7-10, 2019

Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California.  The JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 450 companies, both public and private, are set to deliver presentations to more than 9,000 attendees.

HALTERES' CORE COMPETENCIES

Services

  • Business and Financial Modeling
  • Business Development
  • Clinical Studies and Regulatory
  • Global Sales and Marketing
  • Impact Modeling and Value Creation
  • Intellectual Property
  • Investor Presentations
  • Market and Technology Assessments
  • Medical Practice
  • Portfolio Planning
  • Product and Process Development
  • Strategic and Tactical Planning

Technologies

  • Algorithms / Informatics / Health IT
  • Biomarker Discovery and Validation
  • Biostatistics
  • Companion Diagnostics
  • Digital Health and Wellness
  • Histology / Anatomic and Clinical Pathology
  • Immunodiagnostics
  • Instrument Systems
  • Life Science Research Tools
  • Medical Devices
  • Molecular Diagnostics
  • Next Generation Sequencing

Markets

  • Blood Screening
  • Chronic Diseases
  • Clinical Laboratory Services
  • Global Health
  • Infectious and Chronic Diseases
  • Life Science Research
  • Oncology
  • “Omics” applications
  • Parasitology
  • Pathology
  • Point of Care Testing